-
summarize the goals of management of respiratory allergies.
-
describe the role of allergen immunotherapy in the treatment of respiratory allergic disease.
-
identify and describe the characteristics of patients for whom allergen immunotherapy is indicated.
-
select the right patients for allergen immunotherapy.
About This Course
Respiratory allergic disease has chronic and evolutive characteristics and is displaying increasingly severe forms around the globe. Allergen immunotherapy (AIT) is a unique etiological treatment that is able to modify the course of respiratory allergic disease. This course has been designed to teach healthcare providers about AIT and its place in the management of respiratory allergies.
This course should take you approximately 60 minutes to complete.
This course has a 2-year expiry date of 04 September 2025. If you complete this course after its expiry date, please double check all claims in this course with up-to-date, peer-reviewed information, as the diagnostic or treatment landscape may have changed.
CME/CPD Information
This course has been accredited by the European Accreditation Council for Continuing Medical Education (UEMS-EACCME®) with 1 European CME credit (ECMEC®).
This accreditation certifies the quality and relevance of the educational content.
Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 Credits™.
Learning Outcomes
By the end of this course, you should be able to:
Expert Faculty
This course has been made in close collaboration with:
Course curriculum
-
-
Welcome to the Course
-
-
-
Introduction to Precourse Quiz
-
Precourse Quiz
-
-
-
What is Allergen Immunotherapy?
-
-
-
Acceptance of and Adherence to Allergen Immunotherapy
-
-
-
Selecting the Right Treatment for the Right Patient
-
-
-
Introduction to Final Quiz
-
Final Quiz
-
-
-
Take-Home Messages
-
Course Feedback Survey
-
About this course
- Free
- 10 lessons
- 0 hours of video content
This course has been funded with an educational grant from Stallergenes Greer.